IQVIA Holdings, Inc. (IQV): Price and Financial Metrics
IQVIA Holdings, Inc. (IQV)
Today's Latest Price: $167.47 USD
Updated Oct 23 7:00pm
Add IQV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
IQV Stock Summary
- With a market capitalization of $32,372,610,996, Iqvia Holdings Inc has a greater market value than 93.83% of US stocks.
- IQV's current price/earnings ratio is 245.25, which is higher than 96.98% of US stocks with positive earnings.
- The volatility of Iqvia Holdings Inc's share price is greater than that of only 19.39% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Iqvia Holdings Inc, a group of peers worth examining would be RSG, VRSK, LVS, NDAQ, and LH.
- Visit IQV's SEC page to see the company's official filings. To visit the company's web site, go to www.iqvia.com.
IQV Stock Price Chart Interactive Chart >
IQV Price/Volume Stats
| Current price | $167.47 | 52-week high | $176.00 |
| Prev. close | $169.40 | 52-week low | $81.79 |
| Day low | $166.53 | Volume | 760,587 |
| Day high | $170.77 | Avg. volume | 1,384,523 |
| 50-day MA | $160.91 | Dividend yield | N/A |
| 200-day MA | $146.45 | Market Cap | 32.03B |
IQVIA Holdings, Inc. (IQV) Company Bio
IQVIA provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The company was founded in 1982 and is based in Durham, North Carolina.
IQV Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $167.47 | $98.18 | -42% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Iqvia Holdings Inc. To summarize, we found that Iqvia Holdings Inc ranked in the 34th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Iqvia Holdings Inc ended up being:
- The company's compound free cash flow growth rate over the past 5.45 years comes in at 0.21%; that's greater than 60.17% of US stocks we're applying DCF forecasting to.
- Relative to other stocks in its sector (Healthcare), Iqvia Holdings Inc has a reliance on debt greater than 67.67% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -43% |
| 1% | -43% |
| 2% | -42% |
| 3% | -41% |
| 4% | -41% |
| 5% | -40% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as IQV, try MD, QDEL, GSK, HZNP, and OSMT.
Loading social stream, please wait...